First-Line Medication Selection for New Hypertension
For newly diagnosed hypertension, first-line therapy should include an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB), a calcium channel blocker (CCB), or a thiazide diuretic, with combination therapy often required to achieve blood pressure targets. 1, 2
Initial Treatment Algorithm
Step 1: Lifestyle Modifications
- Implement sodium restriction, DASH diet, regular physical activity, weight management
- Limit alcohol consumption and eliminate smoking
- Sugar restriction (<10% of energy intake)
- Allow maximum 3 months of lifestyle modifications alone for Stage 1 hypertension before adding medications 1
Step 2: Pharmacological Therapy Selection
First-line options (choose based on patient characteristics):
Specific patient considerations:
Step 3: Combination Therapy
- If BP remains uncontrolled on monotherapy, add a second agent from a different class
- Most effective combination: ACE inhibitor/ARB + CCB 1
- Consider single-pill combinations to improve adherence 4
Step 4: Triple Therapy
- If BP remains uncontrolled on dual therapy, add a thiazide diuretic
- Triple combination: ACE inhibitor/ARB + CCB + thiazide diuretic 1
Step 5: Resistant Hypertension
- Add spironolactone or beta-blocker as fourth-line agent 1
Target Blood Pressure Goals
- General adult population: <130/80 mmHg 1, 2
- Older adults (≥65 years): 130-139/70-79 mmHg 1
- Very elderly (≥85 years) or frail: <140/90 mmHg 1
- Patients with diabetes or CKD: <130/80 mmHg 1
Monitoring and Safety Considerations
- Check blood pressure and renal function within 1-2 weeks after initiating or changing medications 1
- Monitor for orthostatic hypotension, especially in elderly patients 1
- For ACE inhibitors/ARBs:
- Monitor renal function and potassium levels 1
- Watch for cough with ACE inhibitors (consider switching to ARB if occurs)
- For thiazide diuretics:
- Avoid if CrCl <30 mL/min 1
- Monitor electrolytes, particularly potassium
- For spironolactone:
Clinical Pearls and Pitfalls
- Don't delay treatment: Uncontrolled hypertension significantly increases cardiovascular risk 2, 5
- Avoid rapid BP reduction: In non-emergency situations, gradually lower BP to prevent organ hypoperfusion
- Don't discontinue medications: Unless clinically indicated, as this can worsen BP control and increase cardiovascular risk 1
- Avoid hydralazine and immediate-release nifedipine: These can cause unpredictable BP drops 6
- Consider home BP monitoring: To confirm diagnosis and monitor treatment effectiveness 4
Special Considerations for Lisinopril
Lisinopril is an effective ACE inhibitor for hypertension with these characteristics:
- Once-daily dosing (24-hour effect)
- Starting dose typically 10 mg daily (range 20-40 mg/day)
- Lower doses needed in elderly, renal impairment, or heart failure patients
- No hepatic metabolism required (beneficial in liver disease)
- Eliminated primarily by kidneys (dose adjustment needed in renal impairment)
- Can be used alone or with other antihypertensives 3, 7